NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Insider Buying Sends Pulse Biosciences Stock Higher

Pulse Biosciences stock jumped after top executives bought $13M in shares, signaling strong confidence in future growth.

Insider Buying Sends Pulse Biosciences Stock Higher
FORM 4
Already have an account? Sign in.
05/12/2026 · 9:50 AM
PLSE
/ Don’t stop at just one post.

Related↓

Wall Street Starts Coverage on PLSE and ENGN: What You Need to Know
01/30/2026 · 9:54 AM

Wall Street Starts Coverage on PLSE and ENGN: What You Need to Know

Mizuho and Jefferies initiate coverage on Pulse Biosciences and enGene, highlighting growth potential, strong clinical data, and upcoming catalysts in biotech.

/ Subscriber only
/ Read more

Feed↓

Adaptive Biotechnologies Plans to Split Its MRD and Immune Medicine Units
06/15/2026 · 4:45 PM

Adaptive Biotechnologies Plans to Split Its MRD and Immune Medicine Units

The company expects to decide the best path by year-end 2026.

/ Subscriber only
Stride Plunges After Losing Major Texas Virtual School Contract
06/15/2026 · 2:52 PM

Stride Plunges After Losing Major Texas Virtual School Contract

Stride shares plunged after Texas' Roscoe ISD decided not to renew its contract for Lone Star Online Academy, representing ~5% of 2025 enrollment. BMO highlights retention risks.

/ Subscriber only
H.C. Wainwright Says CNTX Stock Drop Is 'Overdone' After CTIM-76 Ovarian Cancer Data
06/15/2026 · 1:23 PM

H.C. Wainwright Says CNTX Stock Drop Is 'Overdone' After CTIM-76 Ovarian Cancer Data

Context Therapeutics reported positive Phase 1 data for CTIM-76 in heavily pretreated platinum-resistant ovarian cancer, showing a 29% response rate and good safety, but the stock fell due to small trial size.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2026
Email address Subscribe